Respiratory muscle function in pulmonary hypertension

Not Applicable

• Conditions: I27.0; Primary pulmonary hypertension

• Registration Number: DRKS00003567
• Lead Sponsor: niklinik FreiburgAbt. Pneumologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2009-11-27
• Study Start: 2012-02-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 7

Inclusion Criteria

Established diagnosis of pulmonary hypertension (Dana Point class I) (NYHA class III-IV) and treatment in an established center according to current recommendations.

Exclusion Criteria

Other forms of pulmonary hypertension that are not covered in Dana Point class I
rib cage abnormalities
neuromuscular disorders
systemic steroid therapy
diabetes
cachexia

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of respiratory muscle strength at the beginning and after three weeks of stationary rehabilitation.

Secondary Outcome Measures

Name	Time	Method
Secondary endpoints following rehabilitation are:<br>Increase in lung function parameters<br>Inrease in blood gas parameters (oxygenation)<br>Increase in walking distance<br>Improvement of dyspnea ratings.